Literature DB >> 1310958

HeLa cells grown continuously in protein-free medium: a novel model for the study of virus replication.

J Cinatl1, J Cinatl1, H Rabenau, B Kornhuber, W H Doerr.   

Abstract

Human carcinoma of the cervix cell line HeLa, adapted to continuous growth in a protein-free chemically defined medium, was used as substrate for the replication of several human pathogenic viruses. Growth characteristics of the cells designated as HeLa-PF in protein-free 1:1 nutrient mixture of Dulbecco's modified MEM and Ham's F-12 supplemented with L-ascorbic acid 2-phosphate were similar to those of the cells grown in a serum-supplemented medium. After 30 months (135 subcultures) in the protein-free medium, HeLa-PF cells were infected with poliovirus types 1, 2 and 3; adenovirus types 2 and 5 and herpes simplex virus type 1. Both adenoviruses and polioviruses developed in HeLa-PF cells titers and showed cytopathic effects comparable to those obtained in conventionally grown and maintained cells; in contrast, significantly lower herpes simplex virus type 1 titers and changed characteristics of the cytopathic effects were observed in HeLa-PF cells. The results show that HeLa-PF cells grown continuously in protein-free medium provide a unique system for the study of virus replication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310958     DOI: 10.1159/000150229

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  2 in total

1.  Increased HIV-1 production in chronically infected H9 cells grown in protein-free medium.

Authors:  J Cinatl; J Cinatl; H Rabenau; U Ebener; B Kornhuber; H W Doerr
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Effects of S-acetylglutathione in cell and animal model of herpes simplex virus type 1 infection.

Authors:  Jens-Uwe Vogel; Jaroslav Cinatl; Nurlan Dauletbaev; Sigune Buxbaum; Gernot Treusch; Jindrich Cinatl; Valentin Gerein; Hans Wilhelm Doerr
Journal:  Med Microbiol Immunol       Date:  2003-11-18       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.